Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
JAMA Netw Open. 2020 Oct 1;3(10):e2015665. doi: 10.1001/jamanetworkopen.2020.15665.
There has been a worldwide secular trend toward earlier onset of puberty in the general population. However, it remains uncertain if these changes are paralleled with increased incidence of central precocious puberty (CPP) and normal variant puberty (ie, premature thelarche [PT] and premature adrenarche [PA]) because epidemiological evidence on the time trends in the incidence of these puberty disorders is scarce.
To provide valid epidemiological data on the 20-year secular trend in the incidence rates of CPP and normal variant puberty.
DESIGN, SETTING, AND PARTICIPANTS: This population-based, 20-year cohort study used national registry data for all youth in Denmark registered with an incident diagnosis of CPP, PT, or PA in the Danish National Patient Registry from 1998 to 2017 (N = 8596) using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). We applied the maximum diagnostic age limit for precocious puberty (ie, onset of puberty before age 8 years for girls and age 9 years for boys) with and without a 12-month lag to address time from first contact to final registration in the Danish National Patient Registry. Data analysis was conducted in 2019.
Diagnosis of CPP, PT, or PA.
The age-specific and sex-specific incidence rates of first-time diagnosis of CPP, PT, and PA were estimated using data from the Danish National Patient Registry from 1998 to 2017, and information about the total number of children at risk within the same age groups and sex from Statistics Denmark. Incidences were stratified according to immigration group (Danish origin, first-generation immigrant, second-generation immigrant).
Overall a total 8596 children (7770 [90.4%] girls; median [interquartile] age at diagnosis for boys, 8.0 [7.1-9.0] years; for girls, 8.0 [7.6-8.5] years) were registered with an incident diagnosis of CPP, PT, or PA, of whom 7391 (86.0%) had Danish origin (6671 [90.3%] girls), corresponding to 370 new cases in children with Danish origin per year. The 20-year mean annual incidence rates of CPP, PT, PA, and all 3 conditions per 10 000 girls with Danish origin were 9.2 (95% CI, 8.0 to 10.3), 1.1 (95% CI, 0.7 to 1.5), 1.3 (95% CI, 0.9 to 1.7), and 11.5 (95% CI, 10.3 to 12.8), respectively. For boys with Danish origin, the 20-year mean annual incidence rates per 10 000 boys were lower: 0.9 (95% CI, 0.6 to 1.2), 0.2 (95% CI, 0.1 to 0.4), and 1.1 (95% CI, 0.7 to 1.4) for CPP, PA, and the sum, respectively. There was a 6-fold increase in incidence for girls with Danish origin (from 2.6 per 10 000 to 14.6 per 10 000) and a 15-fold increase for boys with Danish origin (from 0.1 per 10 000 to 2.1 per 10 000). The 20-year mean incidence of CPP and PA among girls in the first-generation and second-generation immigrant groups were greater than that of girls with Danish origin. The incidence rate for CPP per 10 000 girls in the first-generation and second-generation groups were 13.7 (95% CI, 9.3 to 18.2) and 14.2 (95% CI, 4.6 to 23.9), respectively; the incidence rate for PA per 10 000 girls in the first-generation and second-generation groups were 2.0 (95% CI, 0.3 to 3.6) and 1.5 (95% CI, -1.6 to 4.7), respectively. No differences associated with immigration status were observed among boys.
Our findings suggest that the annual incidence of CPP and normal variant puberty has substantially increased in Denmark during the last 20 years. These findings have implications for short-term and long-term health and potentially for the international classification of the reference age of puberty.
在普通人群中,青春期开始的时间出现了全球范围内的季节性趋势。然而,尚不确定这些变化是否与中枢性性早熟(CPP)和正常变异型青春期(即早熟性乳房发育[PT]和早熟性肾上腺功能亢进[PA])的发病率增加有关,因为关于这些青春期障碍的时间趋势的流行病学证据很少。
提供关于 CPP 和正常变异型青春期发病率 20 年季节性趋势的有效流行病学数据。
设计、地点和参与者:本基于人群的 20 年队列研究使用了全国登记数据,这些数据来自丹麦全国患者登记处(1998 年至 2017 年)中所有以 CPP、PT 或 PA 为首发诊断的青年(n=8596),使用的是国际疾病分类第十版(ICD-10)。我们应用了早熟性(即女孩 8 岁前,男孩 9 岁前)的最大诊断年龄限制,同时考虑了从首次接触到最终在丹麦全国患者登记处登记的 12 个月的延迟,以解决这个问题。数据分析于 2019 年进行。
CPP、PT 或 PA 的诊断。
使用 1998 年至 2017 年丹麦全国患者登记处的数据,根据年龄和性别计算了首次诊断为 CPP、PT 和 PA 的年龄特异性和性别特异性发病率,并从丹麦统计局获得了相同年龄组和性别的儿童总数信息。发病率根据移民群体(丹麦血统、第一代移民、第二代移民)进行分层。
共有 8596 名儿童(7770 名女孩[中位数(四分位距)诊断时年龄为 8.0[7.1-8.5]岁;男孩为 8.0[7.0-9.0]岁)被诊断为 CPP、PT 或 PA,其中 7391 名(86.0%)有丹麦血统(6671 名女孩[90.3%]),这意味着每年有 370 名有丹麦血统的儿童出现新病例。在有丹麦血统的女孩中,CPP、PT、PA 和所有 3 种疾病的 20 年平均年发病率分别为 9.2(95%CI,8.0 至 10.3)、1.1(95%CI,0.7 至 1.5)、1.3(95%CI,0.9 至 1.7)和 11.5(95%CI,10.3 至 12.8),男孩的发病率分别为 0.9(95%CI,0.6 至 1.2)、0.2(95%CI,0.1 至 0.4)和 1.1(95%CI,0.7 至 1.4)。丹麦血统的男孩发病率较低,女孩发病率分别为 6 倍(从每 10000 名儿童 2.6 例增加到 14.6 例)和 15 倍(从每 10000 名儿童 0.1 例增加到 2.1 例)。第一代和第二代移民女孩中 CPP 和 PA 的发病率在 20 年内都有所增加,第一代和第二代移民女孩中 CPP 的发病率分别为 13.7(95%CI,9.3 至 18.2)和 14.2(95%CI,4.6 至 23.9),PA 的发病率分别为 2.0(95%CI,0.3 至 3.6)和 1.5(95%CI,-1.6 至 4.7)。在男孩中,没有发现与移民身份相关的差异。
我们的研究结果表明,在过去 20 年中,丹麦 CPP 和正常变异型青春期的年发病率显著增加。这些发现对短期和长期健康有影响,可能对青春期的国际参考年龄分类也有影响。